ARDTNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Ardent Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$11.69−0.26 (-2.18%)
Close on Oct 19, 2026
- Market cap
- $1.67B
- P/E (TTM)
- 21.3
- Dividend yield
- –
Share price
−$2.94 (−20.10%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Ardent Health, Inc. grew revenue 3.3% to $6.41B over the twelve months to Jun 30, 2026.
Revenue
$6.41B
+3.3% vs. a year earlier
EPS, diluted
$0.55
-69.6% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.67B
- P/E ratio
- 21.3
- Price to sales
- 0.26
- Price to book
- 1.24
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $6.41B
- Net income
- $78.23M
- EPS, diluted
- $0.55
- Book value per share
- $9.44
- Diluted shares
- 143M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$6.41B+3.3% YoY
Net income
$78.23M-69.3% YoY
EPS, diluted
$0.55-69.6% YoY
Reported periodTrailing twelve months